In tumor contexts, malignant cells co-opt this pathway to metastasize to CXCL12-rich organs via Gαi-dependent upregulation of integrin α4β1 and cytoskeletal reorganization (Mempel et al., 2024). This evidence concerns the gene CXCL12 and neoplasm.